Technology
Haploys is developing its own technology for opening new horizons to the academic and industrial research community: focused and relevant data from ever more samples or patients matching your budget.


 A new and innovative technology to answer each need:
  		 
Low amounts of DNA
>= 1000 SNPs/100ng of genomic DNA (2006)
High precision
methods avoid complex hybridization and exponential amplification
For genetics: 100% expected (process in evaluation phase)
For gene expression and quantitative analysis: +/- 10% expected (process in evaluation phase)
Extreme Flexibility
Number of samples treated simultaneously: from tens to thousands
Number of genes or genetic markers processed on a single sample: from tens to thousands
Processed samples can be interrogated many times over months-years

Reliability (towards sample or gene confusion),
100% expected through the use of molecular markers and gene identification based on fragment length
Each sample is tracked through molecular labeling
Spurious hybridization signal is discriminated from specific hybridization signal

Optimized Southern/Northern blot based method
Detection on custom instruments with proprietary bioinformatics
Proprietary sample formatting: up to 10’000 patients analyzed simultaneously
Formatted samples can be interrogated many times over months-years